Comparing 28 mm and 31 mm Balloon Cryoablation for Pulmonary Vein Isolation in Atrial Fibrillation Treatment
Led by Hospital Universitario 12 de Octubre · Updated on 2024-11-20
440
Participants Needed
17
Research Sites
60 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two methods of pulmonary vein isolation PVI in patients with paroxysmal or persistent atrial fibrillation AF. The study evaluates whether using a larger 31 mm cryoablation balloon for extended antral isolation is superior to the standard 28 mm balloon for antral isolation in reducing atrial tachyarrhythmia recurrence and arrhythmic load over one year. This trial addresses the impact of larger ablation devices on heart function and arrhythmia outcomes.
Participants receive PVI using either a 28 mm or a 31 mm cryoballoon catheter, both delivering cryoenergy to isolate pulmonary veins. The 28 mm balloon targets antral isolation, while the 31 mm balloon aims for extended antral isolation near the carina, resembling a wide ablation technique. The study is randomized and double-blinded, comparing these two single-shot ablation strategies in a controlled setting.
During the study, patients are monitored for recurrence of atrial tachyarrhythmias lasting more than 30 seconds and overall arrhythmic burden up to 12 months post-procedure. Effectiveness is assessed through procedure times averaging 180 minutes and safety is tracked throughout the study duration. Researchers collect detailed arrhythmia load measurements during episodes and follow participants for adverse events and long-term outcomes, with study participation lasting at least one year.
CONDITIONS
Brief Title
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
Research Team
D
Daniel Rodríguez Muñoz, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosis of paroxysmal or persistent atrial fibrillation within the last 2 years
Clinical indication for pulmonary vein isolation using balloon cryoablation
You will not qualify if you...
Severe left atrial enlargement (indexed volume >48 ml/m2, area >40 cm2, or indexed diameter >3.0 cm/m2)
Previous endocardial or surgical ablation of atrial fibrillation
Severe frailty (Clinical Frailty Scale score 7 or higher) or life expectancy less than 1 year
Inability to understand or give informed consent
Additional left atrial ablations beyond pulmonary veins
Need for catheters other than cryoablation catheter to complete isolation
Contraindication to anticoagulation or intolerance to heparin
Presence of intra-atrial thrombus
Reversible cause of atrial fibrillation
Severe mitral or aortic valve disease
Congenital heart disease
Pregnancy or planned pregnancy within 12 months
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Approximately 3 hours
Participants undergo pulmonary vein isolation using either a 28 mm or 31 mm balloon cryoablation device as part of the ablation procedure for atrial fibrillation.
1 procedure visit (in-person)
Long-term Monitoring
Duration - Up to 12 months
Participants are monitored for recurrence of atrial tachyarrhythmia and arrhythmic load up to 12 months following the ablation procedure.
Follow-up visits scheduled as per protocol up to 12 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Using 320-Detector CT to Measure Heart Tissue Fibrosis in Adults with Atrial Fibrillation
Before Catheter Ablation Treatment
Long-Term Safety and Effectiveness Evaluation of the VARIPULSE Catheter System in Symptomatic Paroxysmal Atrial Fibrillation Management
Evaluating Safety and Effectiveness of Dual Energy THERMOCOOL SMARTTOUCH SF Catheter With TRUPULSE Generator in Persistent Atrial Fibrillation
Evaluating Varipulse Catheter Ablation Using Different Anesthesia Types in Adults With Paroxysmal Atrial Fibrillation
Safety and Effectiveness of the VARIPULSE Catheter System for Treating Persistent Atrial Fibrillation
Using Pulmonary Vein, Superior Vena Cava, and Posterior Wall Isolation
Including Left Atrial Appendage Occlusion Procedures
Randomized Trial Comparing VARIPULSE and FARAWAVE Pulsed Field Ablation Catheters in Treating Persistent Atrial Fibrillation
Randomized, Double-Blind Study Evaluating Oral PKN605 Compared to Placebo in Adults with Atrial Fibrillation to Assess Efficacy, Safety, and Pharmacokinetics
Evaluating BAY 3670549 Compared to Placebo for Treating Atrial Fibrillation with Electrical Cardioversion in Adults
Village Doctor-led Telehealth Care vs Usual Care for Older Adults with Atrial Fibrillation and Heart Failure in Rural China The MIRACLE AF-HF Trial
Telehealth-Supported Village Doctor-Led Trial for Preventing Heart Failure in Older Rural Patients with Atrial Fibrillation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Wide-Antral pulmonary vein isolation in patients undergoing atrial fibrillation ablation with a Single-Shot technique: rationale and design of the WIDER-PVI trial.